Success Stories: We Helped a Staff Scientist from India in the Field of Proteomics of Pathogenesis Achieve NIW Approval, Also Thanks to the Premium Processing Service

Case Summary:

With a Ph.D. in pathology and fundamental research experience, undoubtedly, our client undoubtedly possesses the ability to advance in the field of proteomics of pathogenesis. When he contacted our law firm to file an I-140 NIW (National Interest Waiver) petition on his behalf, we examined more into his degrees and diplomas, and after thoroughly evaluating his credentials, we established that we would lead him to NIW success and countersigned the retainer agreement.

We intended to prove that he is an essential researcher in his field of expertise; therefore, we added essential attributes to his NIW (National Interest Waiver) petition packet. We noted that:

❖ His work has been cited 1179 times by dependent and independent researchers, demonstrating that his publications are widely recognized and relied upon in his chosen field.

❖ We also detailed his contributions to peer-reviewed conference articles, which resulted in 17 peer-reviewed journal articles (5 of them first-authored or co-first-authored), 8 abstracts (7 of them first-authored), 2 preprints (1 of them first-authored), 2 submitted articles, and 1 first-authored book chapter.

❖ He has completed at least 18 reviews to date.

Moreover, our client’s research related to developing mass spectrometry-based proteomic approaches to analyze virus surface glycoproteins to advance vaccine development against viral diseases has great substantial merit and national importance. Among other applications, his research is relevant to enhancing global health outcomes and bolstering healthcare system resiliency.

Additionally, by using mass spectrometry to accurately identify and characterize glycoproteins, his research enables detailed insights into viral structure, mechanisms of infection, and immune evasion strategies. In this way, our client’s research is essential for advancing vaccines that effectively target viral entry points and neutralize infections, curbing the spread of infectious diseases in vulnerable urban populations globally.

To bolster our client’s case further, we added recommendation letters signed by four other expert scholars in the field, one of whom stated:

“Overall, [client’s] work significantly benefits the U.S. by driving progress in mass
spectrometry-based technologies, especially in the realm of vaccine development…Through his work improving the methods used to measure these important protein modifications, [client’s] contributions streamline vaccine development and improve public health outcomes. His work is a crucial asset to national efforts aimed at advancing biomedical technologies and protecting the population against current and emerging infectious diseases.”

Furthermore, due to its clear national importance, our client’s research has been supported with funding from the National Institutes of Health (NIH) and the Bill and Melinda Gates Foundation. This funding is reserved solely for research directed at advancing the national interest, including initiatives that enhance health outcomes and productivity.

Thus, our client’s education, experience, expertise, record of publication and citation, and history of successful research in the field all indicate that he is well-positioned to advance the proposed endeavor.

We are pleased that our efforts and hard work, in this case, paid off well in proving that our client’s major contributions in his field of expertise make him an invaluable asset to the United States; thus, he received his NIW (National Interest Waiver) approval without waiting long. Therefore, we thank him for choosing the North America Immigration Law Group to represent his case and wish him very well as he continues to advance in his proposed field.